Taylor Devices, Inc. filings document governance, compensation and shareholder-vote matters for the Nasdaq-listed manufacturer of shock absorption, rate control and energy storage devices. The definitive proxy statement describes annual meeting proposals, including director election matters, auditor ratification and the 2025 Taylor Devices, Inc. Stock Option Plan.
Form 8-K disclosures report material events such as shareholder voting results and approval of compensatory arrangements. Together, the filings record board election mechanics, independent auditor matters, equity incentive-plan governance and related public-company reporting obligations.
TAYLOR DEVICES, INC. Chief Executive Officer Timothy John Sopko received a grant of stock options covering 7,000 shares of Common Stock as compensation. The options have an exercise price of $56.43 per share and expire on April 18, 2036. Following this grant, he holds 7,000 stock options directly.
TAYLOR DEVICES, INC. director Robert Michael Carey received a grant of stock options representing 7,000 shares of common stock. These options were awarded at an exercise price of 56.43 per share and are exercisable into 7,000 shares of common stock. Following this grant, Carey holds 7,000 derivative securities linked to the company’s stock, with an expiration date of April 18, 2036.
TAYLOR DEVICES, INC. Chief Financial Officer Paul Murray Heary reported a compensation-related equity award. He received a grant of stock options covering 7,000 shares of common stock, giving him the right to buy those shares at an exercise price of $56.43 per share.
The options were granted on April 18, 2026 and are scheduled to expire on April 18, 2036. The filing shows no open-market buying or selling of common stock; instead, it records this grant/award acquisition of derivative securities, leaving him with 7,000 stock options after the transaction.
TAYLOR DEVICES, INC. director John Burgess received a grant of stock options on April 18, 2026. He was awarded options for 7,000 shares of common stock with an exercise price of $56.43 per share. After this compensation grant, he holds options for 7,000 shares directly.
Taylor Devices, Inc. director Armenat Fritz Eric reported a compensation-related grant of stock options. He acquired 7,000 Stock Options (Right to Buy) for the company’s common stock on April 18, 2026.
The options carry an exercise price of $56.43 per share and are scheduled to expire on April 18, 2036. After this award, he holds stock options for 7,000 underlying common shares directly.
TAYLOR DEVICES, INC. director John Burgess exercised stock options to acquire 5,000 shares of common stock at an exercise price of $16.40 per share on April 13, 2026. As part of the same event, 1,574 shares of common stock were withheld to satisfy the exercise price or related tax liability, which is a non-market, tax-withholding disposition rather than an open-market sale. Following these transactions, Burgess directly owns 43,426 shares of Taylor Devices common stock.
Taylor Devices, Inc. reported higher sales and earnings for the nine months ended February 28, 2026. Net revenue grew to $32.7 million from $30.7 million, while net income rose to $6.7 million from $5.7 million, and earnings per share increased to $2.12 from $1.83.
Gross margin dipped slightly to 44% from 45% as cost of goods sold rose faster than revenue, but lower selling, general and administrative expenses helped lift operating income to $6.8 million from $5.9 million. Revenue mix shifted further toward aerospace/defense customers, which represented 66% of nine‑month sales, with structural and industrial customers lower.
The company’s balance sheet remained strong, with cash and cash equivalents of $2.5 million and short‑term investments of $39.2 million. Inventory and maintenance inventory together declined about 10% year over year, while order backlog fell from $33.3 million to $20.8 million, which management attributes to timing of backlog conversion to revenue.
Wax Asset Management, LLC filed an amended ownership report showing it beneficially owns 297,666 shares of Taylor Devices Inc common stock, representing 9.4% of the outstanding class as of 12/31/2025. Wax Asset Management has sole power to vote and dispose of all these shares.
The firm states the shares were acquired and are held in the ordinary course of business, and not with the purpose or effect of changing or influencing control of Taylor Devices. The position is not held on behalf of other parties and is not part of any reported group.
Taylor Devices, Inc. director F. Eric Armenat reported selling his remaining common shares over two days. On January 22, 2026, he sold 2,800 shares of common stock at a price of $71.773 per share. On January 23, 2026, he executed three additional sales of 528 shares at $72.103 per share, 300 shares at $71.19 per share, and 700 shares at $72.85 per share. Following the final transaction, the Form 4 shows he directly owns 0 shares of Taylor Devices common stock.
Taylor Devices, Inc. director F. Eric Armenat reported an option exercise and related share withholding on 01/21/2026. He exercised a stock option for 5,000 shares of common stock at a price of $9.85 per share, increasing his direct common stock holdings to 5,000 shares immediately after the exercise.
In a separate transaction coded “F” the same day, 672 of those shares were withheld at a value of $73.283 per share, typically reflecting shares surrendered to cover taxes. After these transactions, Armenat directly owned 4,328 shares of Taylor Devices common stock, and the reported 5,000-share stock option position was reduced to zero.